Formula & Concentration

ANTIHEMOPHILIC FACTOR (RECOMBINANT)

Manufacturer

Octapharma

Indications

NUWIQ is a recombinant antihemophilic factor [blood coagulation factor VIII (Factor VIII)] indicated in adults and children with Hemophilia A for:

  • On-demand treatment and control of bleeding episodes
  • Perioperative management of bleeding
  • Routine prophylaxis to reduce the frequency of bleeding episodes

NUWIQ is not indicated for the treatment of von Willebrand Disease. (1)

Product Options

Package Size

NDC #

Presentation

250 IU

68982-0139-01

Vial

500 IU

68982-0141-01

Vial

1000 IU

68982-0143-01

Vial

2000 IU

68982-0145-01

Vial

2500 IU

68982-0147-01

Vial

3000 IU

68982-0149-01

Vial

4000 IU

68982-0151-01

Vial

Shelf Life and Storage

Store NUWIQ in the original package to protect the NUWIQ vials from light. Store NUWIQ in powder form at 2 – 8°C (35 – 46°F) for up to 24 months. Do not freeze. During the shelf life, the product may be kept at room temperature [up to 25°C (77°F)] for a single period not exceeding 3 months. After storage at room temperature, do not return the product to the refrigerator. Do not use after the expiration date. Keep the reconstituted solution at room temperature. Do not refrigerate after reconstitution. Use the reconstituted solution immediately or within 3 hours after reconstitution. Discard any remaining solution.